Like we've seen in many parts of the world, RA prescribing in Germany is moving away from JAKi, in response to regulator
Tweet Content
Like we've seen in many parts of the world, RA prescribing in Germany is moving away from JAKi, in response to regulatory safety warnings.
Whether all of this is appropriate or not, we'll have to see...
#ACR24 ABST0503 @RheumNow https://t.co/VSqdCz6zc5
Show on Archive Page
On
Display in Search Results
On
PDQ
Off